KR20100038424A - 항-아밀로이드제로서 피렌제핀 및 그 유도체 - Google Patents

항-아밀로이드제로서 피렌제핀 및 그 유도체 Download PDF

Info

Publication number
KR20100038424A
KR20100038424A KR1020107002421A KR20107002421A KR20100038424A KR 20100038424 A KR20100038424 A KR 20100038424A KR 1020107002421 A KR1020107002421 A KR 1020107002421A KR 20107002421 A KR20107002421 A KR 20107002421A KR 20100038424 A KR20100038424 A KR 20100038424A
Authority
KR
South Korea
Prior art keywords
compound
alkyl
halo
amyloid
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020107002421A
Other languages
English (en)
Korean (ko)
Inventor
안드레아 파이퍼
안드레 스크라텐홀즈
안드레아스 무스
Original Assignee
에이씨 이뮨 에스.에이.
프로테오시스 악티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에이씨 이뮨 에스.에이., 프로테오시스 악티엔게젤샤프트 filed Critical 에이씨 이뮨 에스.에이.
Publication of KR20100038424A publication Critical patent/KR20100038424A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1020107002421A 2007-07-02 2008-07-02 항-아밀로이드제로서 피렌제핀 및 그 유도체 Withdrawn KR20100038424A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07111491 2007-07-02
EP07111491.2 2007-07-02

Publications (1)

Publication Number Publication Date
KR20100038424A true KR20100038424A (ko) 2010-04-14

Family

ID=40020257

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107002421A Withdrawn KR20100038424A (ko) 2007-07-02 2008-07-02 항-아밀로이드제로서 피렌제핀 및 그 유도체

Country Status (13)

Country Link
US (1) US20100247688A1 (cg-RX-API-DMAC7.html)
EP (1) EP2173355A2 (cg-RX-API-DMAC7.html)
JP (1) JP2010531854A (cg-RX-API-DMAC7.html)
KR (1) KR20100038424A (cg-RX-API-DMAC7.html)
CN (1) CN101778634A (cg-RX-API-DMAC7.html)
AU (1) AU2008270247A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0812849A2 (cg-RX-API-DMAC7.html)
CA (1) CA2691844A1 (cg-RX-API-DMAC7.html)
IL (1) IL202768A0 (cg-RX-API-DMAC7.html)
MX (1) MX2009014126A (cg-RX-API-DMAC7.html)
NZ (1) NZ582314A (cg-RX-API-DMAC7.html)
RU (1) RU2010103105A (cg-RX-API-DMAC7.html)
WO (1) WO2009004038A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2387405A2 (en) 2009-01-13 2011-11-23 ProteoSys AG Pirenzepine as an agent in cancer treatment
ES2693152T3 (es) * 2011-05-10 2018-12-07 Kyowa Hakko Kirin Co., Ltd. Compuesto de pirimido-diazepinona
WO2013068592A1 (en) * 2011-11-10 2013-05-16 Fondation Jerome Lejeune Inhibitors of cystathionine beta synthase to reduce the neurotoxic overproduction of endogenous hydrogen sulfide
CN116635034A (zh) * 2020-09-22 2023-08-22 K·E·克拉伦斯-史密斯 用于治疗人低胆碱能障碍的药物组合
CA3192987A1 (en) * 2020-09-22 2022-03-31 Kathleen E. Clarence-Smith Pharmaceutical combination for the treatment of human hypocholinergic disorders
WO2023137098A1 (en) * 2022-01-16 2023-07-20 Winsantor, Inc. Compositions and methods for improving sexual sensory disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795183B1 (de) * 1968-08-20 1972-07-20 Thomae Gmbh Dr K 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-on-derivate und Arzneimittel
DE3818299A1 (de) * 1988-05-30 1989-12-07 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4112014A1 (de) * 1991-04-12 1992-10-15 Thomae Gmbh Dr K Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel zur behandlung von erkrankungen des zentralnervensystems und zur foerderung der cerebralen durchblutung
EP1781300A1 (en) * 2004-07-16 2007-05-09 ProteoSys AG Muscarinic antagonists with parp and sir modulatng activity as agents for inflammatory diseases
MX2008000461A (es) * 2005-07-12 2008-03-10 Abbott Gmbh & Co Kg Compuestos de piridazina como inhibidores de la glucogeno sintasa cinasa 3.

Also Published As

Publication number Publication date
US20100247688A1 (en) 2010-09-30
JP2010531854A (ja) 2010-09-30
WO2009004038A2 (en) 2009-01-08
BRPI0812849A2 (pt) 2014-12-09
IL202768A0 (en) 2010-06-30
AU2008270247A1 (en) 2009-01-08
NZ582314A (en) 2012-04-27
MX2009014126A (es) 2010-03-29
CA2691844A1 (en) 2009-01-08
RU2010103105A (ru) 2011-08-10
WO2009004038A3 (en) 2009-11-26
AU2008270247A2 (en) 2010-01-28
EP2173355A2 (en) 2010-04-14
CN101778634A (zh) 2010-07-14
WO2009004038A8 (en) 2010-03-11

Similar Documents

Publication Publication Date Title
KR101937782B1 (ko) 바클로펜 및 아캄프로세이트에 기초한 신경 장애의 치료
AU2018250214B2 (en) Methods and compositions for treating aging-associated impairments using CCR3-inhibitors
US9867823B2 (en) Neuroprotective bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disorders
ES2847883T3 (es) Uso de inhibidores de LP-PLA2 en el tratamiento y prevención de enfermedades oculares
KR20140041457A (ko) 신경 장애 치료용 신규 조성물
US20170266211A1 (en) Use of a heterocyclic bcl-2 inhibitor for removing senescent cells and treating senescence-associated conditions
EA015256B1 (ru) Производные тетрагидроизохинолина для повышения функции памяти
US20190247426A1 (en) Methods of treating chronic inflammatory diseases
CN102984938A (zh) 轻度认知障碍(mci)和阿尔茨海默氏症的治疗方法
US20100247688A1 (en) Pirenzepine and derivatives thereof as anti-amyloid agents
US9968574B2 (en) Treatment of MCI and Alzheimer's disease
JP2024517653A (ja) 神経細胞プロテオームを崩壊に対して安定化して血管細胞を保護する方法
JP2007537184A (ja) 抗血小板剤に対する耐性を治療するためのジピリダモールの使用
HK1258023A1 (zh) 纯5-ht6受体拮抗剂与nmda受体拮抗剂的组合
US9440985B2 (en) Tricyclic derivatives of N,N′-substituted 3,7-diazabicyclo [3.3.1]nonanes and drugs based thereon
HK1145641A (en) Pirenzepine and derivatives thereof as anti-amyloid agents
KR20210065950A (ko) Ccr3-억제제를 사용한 노화 관련 장애 치료를 위한 방법 및 조성물
CA3111433C (en) Methods and compositions for treating aging-associated impairments using ccr3-inhibitors
ES3062815T3 (en) Compositions for treating aging-associated impairments using ccr3-inhibitors
KR20260049797A (ko) 경도 인지 장애 치료를 위한 병용 요법의 치료제 조성물 및 사용 방법
JP2017132742A (ja) Aβオリゴマー特異的抗体の新規薬理用途
EA041892B1 (ru) Способы и композиции для лечения ассоциированных со старением нарушений с применением ccr3-ингибиторов

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20100202

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid